×

Nano Labs Report to Shareholders

Nano Labs Corp. Logo

DETROIT, April 26, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to provide the following update to shareholders highlighting our progress and our vision for the year 2013.

Dear Shareholders,

We continue to follow our core strategy of developing a diversified investment of nanotechnologies for our shareholders in Nano Labs.

Our core strategy is founded on four main ideals: first, identify and prioritize the obvious problems that we face in the world today; second, to concentrate our resources on developing our proprietary nano technology to evolve common products into new, revolutionary products in order to solve these problems; third, to leverage our international business contacts and networks to introduce these novel solutions to existing problems; and fourth, to work with strategic partners on commercializing these high-value solutions being brought to market in a timely fashion. We're confident that we will continue to create value for our shareholders by executing this core strategy.

Our teams of scientists, designers, and engineers remain focused on creating a portfolio of advanced products that will provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. We are continuing to create products in these industries to provide us the ability to generate revenues from different market sectors, and our hard work we believe is close to yielding significant results.

We have had many exciting highlights this year to date and I would like to take a moment and share my insights on these with you.

Strong Partnerships

Our important partnerships are a testament to our core strategy. Most notably, we are extremely pleased with the advances in our partnership with CIATEQ. They have proven to be a key cornerstone in our company development. We have made exciting progress in creating solutions, prototypes and testing of several new products in the nano medicine, antiviral and pharma applications that we are excited to reveal in the near future. Testing products takes time, but every day we get closer. The upcoming quarter will be an exciting one. Of note, our marketing team has posted a CIATEQ video which is featured on the home page of our website, and I invite you to view it. Currently, we employ four full time employees at the CIATEQ facilities in Queretaro and twenty-one post grad employees under the direction of Dr. Castano working at CIATEQ and our universities facilities.

Dr. Castano's team is focused on all facets that keep our company moving forward. From research and development – preparing samples, measuring effects, and testing samples – to characterizing and producing our nano particles for our new nano products, and developing the commercial formulations of these products, to assisting in the development of the patents and IP protection. We continue to take full advantage of our diversified base of more than 500 peer-reviewed papers, products, and prototypes relating to energy and fuel, health and medicine, food and agriculture, and building and industrial materials. We are continuing to develop our intellectual property and patents – an important cornerstone of our business.

We are pleased to report as well that we added two prestigious members to our Board of Advisors this quarter, Dr. Patrick Barnabe and Mr. Francis Mandy. They will soon be joined by four additional appointments we hope to announce in the coming weeks.

Insightful Innovation

We have continued to strengthen our international partnerships and working with BYR we have completed production of our first commercial line of NC2012, which we have branded nPaint. As our first product entry, the next-generation thermal insulation paint coating provides fire and heat protection at temperatures of up to 1,500 degrees Celsius. The nano thermal coating is resistant to corrosion, rust, water, and oxidization -- making it particularly durable, as does its capability of reflecting up to 82% of ultraviolet rays that, over time, can contribute to deterioration involving structural materials such as PVC. We have refined the development process making this product commercially and economically viable for use across all industry applications. As our first product entry, we believe it is commercially strong and diverse. Of particular note in hotter climates, the potential to reduce air-conditioning related costs by as much as 40% and offer temperate living conditions for those with no power is one of the biggest commercial drivers.

BYR has produced over 1,250 gallons for testing with a variety of international industry partners and distributors. We look forward to reporting in Q2 on these sales efforts. We strongly believe we have bright prospects for long-term international relationships with significant global brand licensing and distribution partners.

In parallel, we have initiated commercial advances into agriculture through our advanced LEDs for agricultural greenhouses. Our innovative "intelligent illumination system" for greenhouses, that works with commercial light-emitting diodes (LEDs) to reduce energy consumption and improve processes contributing to the growth of plant life in agricultural greenhouses. We strongly believe LEDs hold much promise for creating new technologies for the 21st century agriculture.

This coupled with our automated nanotechnology systems to control the dynamics of greenhouse (GH) CO2 gas for improved crop yields, reduced energy consumption, and decreased environmental hazards, shows significant improvements across the board for increased control efficiencies, crop yields, and energy savings for greenhouse farming and agriculture – a multibillion dollar industry in North America alone. Moving forward in 2013 we believe shareholders can look forward to exciting reports as we move ahead licensing the production and distribution of this technology.

We are continuing to develop relationships and pursue strategic partnerships focusing on promoting the commercial development of our synthetic diamonds nanotechnology. As a very low cost and environmentally safe alternative to current synthetic diamond production, used in traditional industrial applications, we believe we are close to announcing a partner for the global marketplace.

Dr. Castano has traveled to 4 countries over the past 3 months, participating in numerous, notable nanotechnology conferences around the world. These conferences have introduced our management team to other international experts and novel applications of nanotechnology, and more importantly allowed us to meet international businesses and strategic partners looking to help commercialize new nanotechnologies in their respective fields.

We promise to continue to update our shareholders, to industry, to government. In this manner, we are updating our website and hope to launch a new site with a suite of tools that will allow us to communicate our new products and update the industry and shareholders alike. We are excited to showcase this in the coming weeks.

Nanotechnology no longer promises to change the world – the change is right now in progress. And I am delighted that we as shareholders of Nano Labs are all aboard a ship headed for what we believe could be profitable and beneficial horizons.

We believe the world is looking at a sea of change in innovative nanotechnology, with research pointing to the prospect of $2.6 trillion in global revenues for the sector – representing 15 per cent of all projected global manufacturing by 2014. These revenues contrast with $13 billion in 2004. That, in our estimation, is phenomenal growth.

We here at Nano Labs believe that we are at the forefront of an exciting age. In my estimation, we are riding the crest of a wave of such a significant impact that it effectively amounts to a new American industrial revolution.

We are working to create products and materials that come with the satisfying investment benefit of making our industries stronger, our economies healthier, and our environment safer. Indeed, it's amazing what science and industry are now capable of achieving through the modification and manipulation of matter at molecular and atomic scales.

Respectfully on behalf of the Board,

Mr. Bernardo Camacho Chavarria

President, Nano Labs

About Nano Labs

Nano Labs Corp. (CTLE) is a nanotechnology company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us.

The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293

Forward-looking statements

This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.

CONTACT: Bernardo Camacho Chavarria President 1 (888) 806-2315

Source:Nano Labs Corp.